Pascal Maisonobe

2.2k total citations
87 papers, 1.6k citations indexed

About

Pascal Maisonobe is a scholar working on Neurology, Rehabilitation and Psychiatry and Mental health. According to data from OpenAlex, Pascal Maisonobe has authored 87 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Neurology, 29 papers in Rehabilitation and 18 papers in Psychiatry and Mental health. Recurrent topics in Pascal Maisonobe's work include Botulinum Toxin and Related Neurological Disorders (61 papers), Stroke Rehabilitation and Recovery (29 papers) and Cerebral Palsy and Movement Disorders (18 papers). Pascal Maisonobe is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (61 papers), Stroke Rehabilitation and Recovery (29 papers) and Cerebral Palsy and Movement Disorders (18 papers). Pascal Maisonobe collaborates with scholars based in France, United Kingdom and Portugal. Pascal Maisonobe's co-authors include Mark Versavel, David A. Cherry, Emmanuelle Vincent, Rafael Gálvez, R. Sabatowski, Lynne Turner‐Stokes, Klemens Fheodoroff, Jorge Jacinto, Benjamin Zakine and V.P. Misra and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Pascal Maisonobe

80 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pascal Maisonobe France 21 898 393 317 292 289 87 1.6k
G. Gronseth United States 7 1.0k 1.1× 663 1.7× 30 0.1× 128 0.4× 232 0.8× 7 1.7k
Lorenzo Rinaldo United States 23 576 0.6× 59 0.2× 110 0.3× 284 1.0× 89 0.3× 99 1.5k
Jong‐Ho Park South Korea 21 328 0.4× 83 0.2× 116 0.4× 234 0.8× 107 0.4× 82 1.3k
J. D. England United States 6 1.6k 1.7× 447 1.1× 29 0.1× 91 0.3× 102 0.4× 7 2.1k
Louis H. Weimer United States 20 570 0.6× 353 0.9× 28 0.1× 235 0.8× 60 0.2× 39 1.5k
Roberto D’Alessandro Italy 20 271 0.3× 253 0.6× 62 0.2× 101 0.3× 288 1.0× 71 1.2k
Ralf Becker Germany 19 396 0.4× 122 0.3× 42 0.1× 234 0.8× 112 0.4× 43 922
Maria Matteis Italy 21 417 0.5× 251 0.6× 43 0.1× 124 0.4× 245 0.8× 40 1.5k
Yair Bechor Israel 18 275 0.3× 87 0.2× 151 0.5× 54 0.2× 134 0.5× 27 937
Andrea Alberti Italy 18 218 0.2× 315 0.8× 45 0.1× 96 0.3× 575 2.0× 63 1.4k

Countries citing papers authored by Pascal Maisonobe

Since Specialization
Citations

This map shows the geographic impact of Pascal Maisonobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pascal Maisonobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pascal Maisonobe more than expected).

Fields of papers citing papers by Pascal Maisonobe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pascal Maisonobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pascal Maisonobe. The network helps show where Pascal Maisonobe may publish in the future.

Co-authorship network of co-authors of Pascal Maisonobe

This figure shows the co-authorship network connecting the top 25 collaborators of Pascal Maisonobe. A scholar is included among the top collaborators of Pascal Maisonobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pascal Maisonobe. Pascal Maisonobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zorowitz, Richard D., Sergiu Groppa, David Hernández, et al.. (2025). How many stroke survivors develop problematic spasticity requiring pharmacological therapy? An international (Europe and USA) observational study protocol. BMJ Open. 15(1). e087404–e087404.
2.
Rosales, Raymond L., Nicholas V.C. Chia, Khean Jin Goh, et al.. (2024). Botulinum toxin A injection for post-stroke upper limb spasticity and rehabilitation practices from centers across Asian countries. Frontiers in Neurology. 15. 1335365–1335365. 2 indexed citations
3.
Tapiador, Noemí, Consuelo Tudela, Marta López‐Yurda, et al.. (2024). Botulinum Toxin Type A (BoNT-A) Use for Post-Stroke Spasticity: A Multicenter Study Using Natural Language Processing and Machine Learning. Toxins. 16(8). 340–340. 1 indexed citations
4.
Esquenazi, Alberto, et al.. (2024). Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study. Archives of Physical Medicine and Rehabilitation. 106(6). 894–901. 2 indexed citations
5.
Esquenazi, Alberto, et al.. (2023). Clinical presentation of patients with lower limb spasticity undergoing routine treatment with botulinum toxin: baseline findings from an international observational study. Journal of Rehabilitation Medicine. 55. jrm4257–jrm4257. 5 indexed citations
6.
Turner‐Stokes, Lynne, Klemens Fheodoroff, Jorge Jacinto, et al.. (2021). The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: A first psychometric evaluation. Journal of Rehabilitation Medicine. 54. jrm00243–jrm00243. 1 indexed citations
7.
Turner‐Stokes, Lynne, Klemens Fheodoroff, Jorge Jacinto, et al.. (2021). The spasticity-related quality of life 6-dimensions instrument in upper-limb spasticity: Development and responsiveness. Journal of Rehabilitation Medicine. 54. jrm00244–jrm00244. 3 indexed citations
8.
Ip, Chi Wang, et al.. (2021). Behandlungszufriedenheit bei Patienten mit zervikaler Dystonie. Der Nervenarzt. 92(12). 1268–1275. 1 indexed citations
9.
Turner‐Stokes, Lynne, et al.. (2020). Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study. Journal of Rehabilitation Medicine. 53(1). jrm00133–jrm00133. 14 indexed citations
10.
Lejeune, Thierry, Svetlana Khatkova, Lynne Turner‐Stokes, et al.. (2020). Abobotulinumtoxina injections in shoulder muscles to improve adult upper limb spasticity: Results from a phase 4 real-world study and a phase 3 open-label trial. Journal of Rehabilitation Medicine. 52(6). jrm00068–jrm00068. 5 indexed citations
11.
12.
13.
Turner‐Stokes, Lynne, et al.. (2018). Relief of spasticity-related pain with botulinum neurotoxin-A (bont-A) in real life practice. Post-hoc analysis from a large international cohort series. Annals of Physical and Rehabilitation Medicine. 61. e67–e68. 4 indexed citations
14.
Misra, V.P., et al.. (2017). INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin. Journal of Neurology. 265(2). 402–409. 16 indexed citations
15.
16.
17.
Martín-Richard, Marta, Bartomeu Massutí, Vicente Alonso, et al.. (2013). Antiproliferative effects of lanreotide autogel in patients with progressive, well-differentiated neuroendocrine tumours: a Spanish, multicentre, open-label, single arm phase II study. BMC Cancer. 13(1). 427–427. 59 indexed citations
18.
Mariani, Pascale, Joëlle Blumberg, Alain Landau, et al.. (2012). Symptomatic Treatment With Lanreotide Microparticles in Inoperable Bowel Obstruction Resulting From Peritoneal Carcinomatosis: A Randomized, Double-Blind, Placebo-Controlled Phase III Study. Journal of Clinical Oncology. 30(35). 4337–4343. 37 indexed citations
19.
Bakheit, A. M. O., Benjamin Zakine, Pascal Maisonobe, et al.. (2010). The profile of patients and current practice of treatment of upper limb muscle spasticity with botulinum toxin type A: an international survey. International Journal of Rehabilitation Research. 33(3). 199–204. 58 indexed citations
20.
Campion, Jean‐Pierre, Jean‐Marc Regimbeau, Joëlle Blumberg, et al.. (2009). Randomized, Placebo-Controlled, Double-Blind Study of the Efficacy of Lanreotide 30 mg PR in the Treatment of Pancreatic and Enterocutaneous Fistulae. Annals of Surgery. 250(6). 872–877. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Gronseth Breakdown of academic impact, for papers by Lorenzo Rinaldo Breakdown of academic impact, for papers by Jong‐Ho Park Breakdown of academic impact, for papers by J. D. England Breakdown of academic impact, for papers by Louis H. Weimer Breakdown of academic impact, for papers by Roberto D’Alessandro Breakdown of academic impact, for papers by Ralf Becker Breakdown of academic impact, for papers by Maria Matteis Breakdown of academic impact, for papers by Yair Bechor Breakdown of academic impact, for papers by Andrea Alberti
Rankless by CCL
2026